OGD2 Pharma SAS is a Remora Biotech company headquartered in Nantes (France), advancing a proprietary OAcGD2-targeted antibody platform.

Our vision is to lead the O-acetylated GD2 (OAcGD2) antibody category – as the sole company developing proprietary antibodies against this novel antigen – and to establish a new generation of precision immunotherapies for neuroblastoma and other OAcGD2-expressing cancers.

Our mission is to advance our anti-OAcGD2 platform into clinical development through key strategic partnerships, accelerating first-in-class OAcGD2-directed therapies to children with neuroblastoma and expanding into additional high-need oncology indications.

OGD2 Pharma

Org chart

Teams

Offices

OGD2 Pharma

Org chart

Teams

Offices

Related companies